Peter Ordentlich

(Dr. Peter Ordentlich Ph.D.)

Currently holds a position at Syndax Pharmaceuticals Inc

Positions

Position Company Period
Chief Scientific Officer Syndax Pharmaceuticals Inc Sept. 1, 2016 -
Chief Technology Officer Syndax Pharmaceuticals Inc Nov. 1, 2013 - Sept. 1, 2016
Vice President of Translational Medicine, Founder Syndax Pharmaceuticals Inc Jan. 1, 2012 - Oct. 1, 2013
Peter Ordentlich's trades of Syndax Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-02-17 2023-02-15 PS Planned sale
17,428 -100.0%
25.84
USD 450,404
17,428 -100.0% 25.84 USD 450,404
2023-02-17 2023-02-15 PS Planned sale
7,572 -100.0%
25.84
USD 195,688
7,572 -100.0% 25.84 USD 195,688
2023-02-03 2023-02-01 S Sale
69 -100.0%
28.43
USD 1,962
69 -100.0% 28.43 USD 1,962
2022-12-02 2022-12-02 PS Planned sale
17,200 -98.5%
25.05
USD 430,936
17,200 -98.5% 25.05 USD 430,936
2022-12-02 2022-12-01 PS Planned sale
4,028 -93.8%
25.01
USD 100,746
4,028 -93.8% 25.01 USD 100,746
2022-12-02 2022-12-01 PS Planned sale
3,772 -93.4%
25.01
USD 94,343
3,772 -93.4% 25.01 USD 94,343
2022-08-26 2022-08-24 PS Planned sale
2,154 -89.0%
25.04
USD 53,927
2,154 -89.0% 25.04 USD 53,927
2022-08-26 2022-08-24 PS Planned sale
22,846 -98.9%
25.04
USD 571,966
22,846 -98.9% 25.04 USD 571,966
2022-02-03 2022-02-01 S Sale
1,412 -100.0%
16.65
USD 23,510
1,412 -100.0% 16.65 USD 23,510
2020-11-25 2020-11-23 S Sale
16,334 -100.0%
22.89
USD 373,924
16,334 -100.0% 22.89 USD 373,924
2020-11-25 2020-11-23 S Sale
7,954 -32.7%
23.58
USD 187,594
7,954 -32.7% 23.58 USD 187,594
2020-11-25 2020-11-23 S Sale
5,684 -19.0%
23.33
USD 132,603
5,684 -19.0% 23.33 USD 132,603
// ... existing code ... // ... rest of the file ...